Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer




+44 (0)20 3313 3759eric.aboagye




Mrs Maureen Francis +44 (0)20 7594 2793




GN1Commonwealth BuildingHammersmith Campus





Eric Aboagye is Professor of Cancer Pharmacology & Molecular Imaging and Director of the CRUK-EPSRC-MRC-NIHR Comprehensive Cancer Imaging Centre. He joined the college after a PhD at the CRUK Beatson Laboratories in Glasgow, UK and post-doc fellowship at The Johns Hopkins University & Hospital in Baltimore, USA. His group is interested in the discovery and development of new methods for experimental and clinical cancer molecular imaging. In the past 5 years, the team has invented and translated three novel cancer diagnostics into human application. He has acted as an advisor to GE-Healthcare, GSK, Roche and Novartis.

Professor Aboagye was recipient of the 2009 Sir Mackenzie Davidson Medal and was  elected as a Fellow of the Academy of Medical Sciences in 2010. Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge or for conspicuous service to healthcare.



Welgemoed C, Spezi E, Riddle P, et al., 2023, Clinical evaluation of atlas-based auto-segmentation in breast and nodal radiotherapy., Br J Radiol, Vol:96

Chen M, Copley SJ, Viola P, et al., 2023, Radiomics and artificial intelligence for precision medicine in lung cancer treatment., Semin Cancer Biol, Vol:93, Pages:97-113

Hunter B, Bunce C, Blackledge M, et al., 2023, Response to A. Eleuteri regarding "A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules"., Ebiomedicine, Vol:94

Aboagye E, Islam S, Inglese M, et al., 2023, Feasibility of [18F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study, European Journal of Nuclear Medicine and Molecular Imaging, ISSN:0340-6997

Aboagye E, Aravind P, Popat S, et al., 2023, A subset of non-small cell lung cancer patients treated with pemetrexed show 18f-fluorothymidine ‘flare’ on positron emission tomography, Cancers, Vol:15, ISSN:2072-6694, Pages:1-14

More Publications